RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SymBio Pharmaceuticals Stock

SymBio Pharmaceuticals ROCE 2024

SymBio Pharmaceuticals ROCE

-0.11

Ticker

4582.T

ISIN

JP3383050006

WKN

A1JMJE

In 2024, SymBio Pharmaceuticals's return on capital employed (ROCE) was -0.11, a -148.77% increase from the 0.23 ROCE in the previous year.

SymBio Pharmaceuticals Aktienanalyse

What does SymBio Pharmaceuticals do?

SymBio Pharmaceuticals Ltd is a company specializing in the development and marketing of medical products. The company, based in Japan, was founded in 2005 and currently employs over 300 employees. SymBio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling SymBio Pharmaceuticals's Return on Capital Employed (ROCE)

SymBio Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing SymBio Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

SymBio Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in SymBio Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about SymBio Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of SymBio Pharmaceuticals this year?

The ROCE of SymBio Pharmaceuticals is -0.11 undefined this year.

How has the ROCE (Return on Capital Employed) of SymBio Pharmaceuticals developed compared to the previous year?

The ROCE of SymBio Pharmaceuticals has increased by -148.77% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of SymBio Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that SymBio Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of SymBio Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that SymBio Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from SymBio Pharmaceuticals impact the company?

An increase in the ROCE of SymBio Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of SymBio Pharmaceuticals affect the company?

A decrease in ROCE of SymBio Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of SymBio Pharmaceuticals?

Some factors that can affect SymBio Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of SymBio Pharmaceuticals so important for investors?

The ROCE of SymBio Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can SymBio Pharmaceuticals take to improve the ROCE?

To improve the ROCE, SymBio Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does SymBio Pharmaceuticals pay?

Over the past 12 months, SymBio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SymBio Pharmaceuticals is expected to pay a dividend of 0 JPY.

What is the dividend yield of SymBio Pharmaceuticals?

The current dividend yield of SymBio Pharmaceuticals is .

When does SymBio Pharmaceuticals pay dividends?

SymBio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SymBio Pharmaceuticals?

SymBio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of SymBio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is SymBio Pharmaceuticals located?

SymBio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von SymBio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SymBio Pharmaceuticals from 9/14/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 9/14/2024.

When did SymBio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/14/2024.

What was the dividend of SymBio Pharmaceuticals in the year 2023?

In the year 2023, SymBio Pharmaceuticals distributed 0 JPY as dividends.

In which currency does SymBio Pharmaceuticals pay out the dividend?

The dividends of SymBio Pharmaceuticals are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SymBio Pharmaceuticals

Our stock analysis for SymBio Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SymBio Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.